首页> 美国卫生研究院文献>EXCLI Journal >miRNA regulation during cardiac development and remodeling in cardiomyopathy
【2h】

miRNA regulation during cardiac development and remodeling in cardiomyopathy

机译:心肌病心脏发育和重塑期间的miRNA调节

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

miRNAs have been found to play a major role in cardiomyopathy, a heart muscle disorder characterized by cardiac dysfunction. Several miRNAs including those involved in heart development are found to be dysregulated in cardiomyopathy. These miRNAs act either directly or indirectly by controlling the genes involved in normal development and functioning of the heart. Indirectly it also targets modifier genes and genes involved in signaling pathways. In this review, miRNAs involved in heart development, including dysregulation of miRNA which regulate various genes, modifiers and notch signaling pathway genes leading to cardiomyopathy are discussed. A study of these miRNAs would give an insight into the mechanisms involved in the processes of heart development and disease. Apart from this, information gathered from these studies would also generate suitable therapeutic targets in the form of antagomirs which are chemically engineered oligonucleotides used for silencing miRNAs.
机译:已经发现miRNA在心肌病中起主要作用,心肌病是一种以心脏功能障碍为特征的心肌疾病。发现一些miRNA,包括参与心脏发育的miRNA在心肌病中失调。这些miRNA通过控制参与心脏正常发育和功能的基因直接或间接起作用。它也间接靶向修饰基因和信号通路中涉及的基因。在这篇综述中,讨论了与心脏发育有关的miRNA,包括调节多种基因,修饰因子和Notch信号通路基因的miRNA失调,这些基因导致心肌病。对这些miRNA的研究将有助于深入了解心脏发育和疾病过程中涉及的机制。除此之外,从这些研究中收集到的信息还将以antagomir的形式产生合适的治疗靶标,它们是用于沉默miRNA的化学工程寡核苷酸。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号